cancer test articles & resources on Made-in-China.com

The FDA Has Approved a Non-Invasive Test for Colorectal Cancer

Aug 15, 2014

People over 50, rejoice! The FDA has approved a non-invasive test for colorectal cancer, and it may not take years to obtain. Mayo Clinic gastroenterologist David Ahlquist co-invented the test, Cologuard, which detects the presence of ...

Tags: FDA, Health, Medicine

NYSDOH Conditional Approval for Rosetta Kidney Cancer Test Is Resched by Rosetta Genomics

Dec 11, 2013

Rosetta Genomics, a provider of microRNA-based molecular diagnostics, has obtained a conditional approval from the New York State Department of Health (NYSDOH) for its Rosetta Kidney Cancer Test for testing on patient samples from the ...

Tags: Rosetta Kidney Cancer, Medicine

The Presence of Breast Cancer Cells Indicating a Blood Test May Be Possible

Nov 18, 2013

Preliminary studies identified the presence of breast cancer cells from serum biomarkers indicating a blood test may be possible, U.S. researchers say. Study leader biomedical engineer Tony Hu of Houston Methodist Research Institute in ...

Tags: breast, cancer, test, horizon

Myplan Lung Cancer Test Was Launched by Myriad Genetics

Oct 31, 2013

Myriad Genetics, a US-based molecular diagnostic company, has launched a new prognostic test, Myriad myPlan Lung Cancer, for patients diagnosed with early-stage lung adenocarcinoma. myPlan lung cancer test is an RNA expression panel of 31 ...

Tags: Myriad Genetics, molecular diagnostic company

Myriad Genetics Has Launched Myrisk Hereditary Cancer

Sep 9, 2013

Molecular diagnostic company Myriad Genetics has launched myRisk Hereditary Cancer, a new multi-gene diagnostic test for hereditary cancer testing. The new test analyses 25 genes that are associated with breast, colorectal, ovarian, ...

Tags: Multi-Gene Test, Medicine

Clinical Laboratory Permit to Genetic Technologies Is Issued by New York

Sep 3, 2013

Genetic Technologies has received its clinical laboratory permit from the New York State Department of Health (DoH). Genetic Technologies received a positive Laboratory Evaluation Report with "No significant deficiencies" following an ...

Tags: Health, Medicine, Genetic Technologies

A New Breast Cancer Test Help Women Avoid Unnecessary Chemotherapy

Jul 4, 2013

Scientists at the Institute of Cancer Research, London, The Royal Marsden NHS Foundation Trust and Queen Mary University of London have developed a new breast cancer test, dubbed as PAM50, to help women avoid unnecessary chemotherapy. The ...

Tags: Breast Cancer, Chemotherapy

Prostate Cancer Test Study Results Are Presented by Mdxhealth

Feb 21, 2013

MDxHealth has presented results from two studies of its DNA methylation-based assay at the ASCO Genitourinary Cancers Symposium 2013, held at Orlando, Florida, US from 14 - 16 February 2013. The epigenetic assay, ConfirmMDx for Prostate ...

Tags: MDxHealth, Prostate Cancer, clinical pathologist

Biopharmaceutical and OPKO Health Has Acquired Silcon Comercio

Feb 19, 2013

Biopharmaceutical and diagnostics company OPKO Health has acquired Brazilian pharmaceutical company Silcon Comércio, Importacao E Exportacao de Produtos Farmaceuticos e Cosmeticos. The acquisition is expected to expand OPKO's ...

Tags: OPKO Health, Silcon, Biopharmaceutical

OPKO Health Has Signed a Definite Agreement to Acquire Sao Paulo

Dec 28, 2012

OPKO Health has signed a definite agreement to acquire Sao Paulo, Brazil based pharmaceutical company Silcon Comércio, Importacao E Exportacao de Produtos Farmaceuticos e Cosmeticos. The acquisition is expected to expand OPKO's ...

Tags: OPKO, pharmaceutical company, test cassettes, commercial synergies

Phenogen Sciences Unveils a Non-Invasive Genetic Risk Assessment Test for Women

Dec 17, 2012

Phenogen Sciences, a subsidiary of Genetic Technologies, has unveiled a non-invasive genetic risk assessment test for women with estrogen-receptor positive breast cancer. The BREVAGen uses patients oral-swab samples to calculate patient's ...

Tags: non-invasive genetic risk assessment test, cancer test

Quest Diagnostics Has Introduced a Molecular Cervical Cancer Test

Dec 4, 2012

Quest Diagnostics has introduced a molecular cervical cancer test based on National Institutes of Health's TERC gene marker to identify molecular changes to cervical cells that increase the chance of a woman to develop cervical cancer. ...

Tags: cervical cancer TERC test, Quest Diagnostics, TERC results

National Institutes of Health's National Center Awards $100,000 STTR

Aug 23, 2012

National Institutes of Health's National Center For Advancing Translational Sciences has awarded $100,000 small business technology transfer program (STTR) Phase I grant to Transgenomic to develop a genetic test that can detect pancreatic ...

Tags: genetic test, ICE COLD-PCR, genetic information, Pancreatic Cancer Test

cancer test

Related Products